Annual Cash & Cash Equivalents
$9.70 M
+$9.25 M+2032.09%
December 31, 2023
Summary
- As of March 10, 2025, UNCY annual cash & cash equivalents is $9.70 million, with the most recent change of +$9.25 million (+2032.09%) on December 31, 2023.
- During the last 3 years, UNCY annual cash & cash equivalents has risen by +$9.70 million (+100.00%).
- UNCY annual cash & cash equivalents is now -41.49% below its all-time high of $16.58 million, reached on December 31, 2021.
Performance
UNCY Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$32.35 M
-$9.43 M-22.58%
September 30, 2024
Summary
- As of March 10, 2025, UNCY quarterly cash and cash equivalents is $32.35 million, with the most recent change of -$9.43 million (-22.58%) on September 30, 2024.
- Over the past year, UNCY quarterly cash and cash equivalents has stayed the same.
- UNCY quarterly cash and cash equivalents is now -33.89% below its all-time high of $48.93 million, reached on March 31, 2024.
Performance
UNCY Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
UNCY Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +2032.1% | 0.0% |
3 y3 years | +100.0% | 0.0% |
5 y5 years | +10000.0% | 0.0% |
UNCY Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -41.5% | +2032.1% | -33.9% | +7009.2% |
5 y | 5-year | -41.5% | -100.0% | -33.9% | -100.0% |
alltime | all time | -41.5% | -100.0% | -33.9% | -100.0% |
Unicycive Therapeutics Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $32.35 M(-22.6%) |
Jun 2024 | - | $41.78 M(-14.6%) |
Mar 2024 | - | $48.93 M(+404.4%) |
Dec 2023 | $9.70 M(+2032.1%) | $9.70 M(-32.4%) |
Sep 2023 | - | $14.35 M(-23.8%) |
Jun 2023 | - | $18.82 M(-22.7%) |
Mar 2023 | - | $24.33 M(+5247.7%) |
Dec 2022 | $455.00 K | $455.00 K(-93.5%) |
Sep 2022 | - | $7.01 M(-33.7%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $10.57 M(-22.4%) |
Mar 2022 | - | $13.62 M(-17.8%) |
Dec 2021 | $16.58 M(>+9900.0%) | $16.58 M(-8.0%) |
Sep 2021 | - | $18.01 M(>+9900.0%) |
Jun 2021 | - | $1000.00(-99.3%) |
Mar 2021 | - | $147.00 K(>+9900.0%) |
Dec 2020 | $0.00(-100.0%) | - |
Dec 2020 | - | $0.00 |
Dec 2019 | $15.00 K | - |
FAQ
- What is Unicycive Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Unicycive Therapeutics?
- What is Unicycive Therapeutics annual cash & cash equivalents year-on-year change?
- What is Unicycive Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Unicycive Therapeutics?
- What is Unicycive Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Unicycive Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of UNCY is $9.70 M
What is the all time high annual cash & cash equivalents for Unicycive Therapeutics?
Unicycive Therapeutics all-time high annual cash & cash equivalents is $16.58 M
What is Unicycive Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, UNCY annual cash & cash equivalents has changed by +$9.25 M (+2032.09%)
What is Unicycive Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of UNCY is $32.35 M
What is the all time high quarterly cash and cash equivalents for Unicycive Therapeutics?
Unicycive Therapeutics all-time high quarterly cash and cash equivalents is $48.93 M
What is Unicycive Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, UNCY quarterly cash and cash equivalents has changed by $0.00 (0.00%)